Summary Keywords Alzheimers disease, clinical trial, cognitive dysfunction, GLP-1 receptor agonist, neuroinflammation, neuroprotection, semaglutide, vascular dementia Citation Alhowail AH, Al Mouslem AK, Almatrafi MA and Aldubayan MA (2026) Semaglutide in cognitive dysfunction: neuroprotective potential, clinical trial limitations, and a prevention-focused framework
The texture is rich but not sticky, so it sinks in and leaves a soft, healthy-looking finish
N Engl J Med 383:22192229 Pitt B, Filippatos G, Agarwal R, for the FIGARO-DKD Investigators et al (2021) Cardiovascular events with finerenone in kidney disease and type 2 diabetes
FAK-Paxillin Pathway: It activates the focal adhesion kinase (FAK) pathway, which is essential for cell migration and attachment, allowing repair cells to anchor to the site of damage and begin rebuilding